Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.

Halliday BJ, Fukuzawa R, Markie DM, Grundy RG, Ludgate JL, Black MA, Skeen JE, Weeks RJ, Catchpoole DR, Roberts AGK, Reeve AE, Morison IM.

PLoS Genet. 2018 Jun 18;14(6):e1007399. doi: 10.1371/journal.pgen.1007399. eCollection 2018 Jun.

2.

The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour.

Fukuzawa R, Anaka MR, Morison IM, Reeve AE.

PLoS One. 2017 Oct 17;12(10):e0186333. doi: 10.1371/journal.pone.0186333. eCollection 2017.

3.

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.

McInnes T, Zou D, Rao DS, Munro FM, Phillips VL, McCall JL, Black MA, Reeve AE, Guilford PJ.

BMC Cancer. 2017 Mar 28;17(1):228. doi: 10.1186/s12885-017-3226-4.

4.

Biallelic DICER1 mutations occur in Wilms tumours.

Wu MK, Sabbaghian N, Xu B, Addidou-Kalucki S, Bernard C, Zou D, Reeve AE, Eccles MR, Cole C, Choong CS, Charles A, Tan TY, Iglesias DM, Goodyer PR, Foulkes WD.

J Pathol. 2013 Jun;230(2):154-64. doi: 10.1002/path.4196.

5.

Global demethylation in loss of imprinting subtype of Wilms tumor.

Ludgate JL, Le Mée G, Fukuzawa R, Rodger EJ, Weeks RJ, Reeve AE, Morison IM.

Genes Chromosomes Cancer. 2013 Feb;52(2):174-84. doi: 10.1002/gcc.22017. Epub 2012 Oct 17.

PMID:
23074036
6.

Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients.

Girardin A, McCall J, Black MA, Edwards F, Phillips V, Taylor ES, Reeve AE, Kemp RA.

Int J Cancer. 2013 Apr 15;132(8):1842-50. doi: 10.1002/ijc.27855. Epub 2012 Oct 20.

7.

T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer.

Kemp RA, Black MA, McCall J, Yoon HS, Phillips V, Anjomshoaa A, Reeve AE.

J Exp Clin Cancer Res. 2011 Aug 24;30:78. doi: 10.1186/1756-9966-30-78.

8.

WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.

Fukuzawa R, Holman SK, Chow CW, Savarirayan R, Reeve AE, Robertson SP.

J Med Genet. 2010 Nov;47(11):791-4. doi: 10.1136/jmg.2010.080663. Epub 2010 Aug 2.

PMID:
20679664
9.

Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis.

Lu AT, Salpeter SR, Reeve AE, Eschrich S, Johnston PG, Barrier AJ, Bertucci F, Buckley NS, Salpeter EE, Lin AY.

Clin Colorectal Cancer. 2009 Oct;8(4):207-14. doi: 10.3816/CCC.2009.n.035. Review.

PMID:
19822511
10.

Slow proliferation as a biological feature of colorectal cancer metastasis.

Anjomshoaa A, Nasri S, Humar B, McCall JL, Chatterjee A, Yoon HS, McNoe L, Black MA, Reeve AE.

Br J Cancer. 2009 Sep 1;101(5):822-8. doi: 10.1038/sj.bjc.6605229. Epub 2009 Aug 4.

11.

Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer.

Anjomshoaa A, Lin YH, Black MA, McCall JL, Humar B, Song S, Fukuzawa R, Yoon HS, Holzmann B, Friederichs J, van Rij A, Thompson-Fawcett M, Reeve AE.

Br J Cancer. 2008 Sep 16;99(6):966-73.

12.

Canonical WNT signalling determines lineage specificity in Wilms tumour.

Fukuzawa R, Anaka MR, Weeks RJ, Morison IM, Reeve AE.

Oncogene. 2009 Feb 26;28(8):1063-75. doi: 10.1038/onc.2008.455. Epub 2009 Jan 12.

PMID:
19137020
13.

PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.

Hueber PA, Fukuzawa R, Elkares R, Chu L, Blumentkrantz M, He SJ, Anaka MR, Reeve AE, Eccles M, Jabado N, Iglesias DM, Goodyer PR.

Pediatr Dev Pathol. 2009 Sep-Oct;12(5):347-54. doi: 10.2350/08-05-0466.1.

PMID:
18666806
14.
15.

Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.

Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE.

J Pathol. 2008 Aug;215(4):377-87. doi: 10.1002/path.2366.

PMID:
18484682
16.

Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors.

Fukuzawa R, Reeve AE.

J Pediatr Hematol Oncol. 2007 Sep;29(9):589-94. Review.

PMID:
17805030
17.

Genome wide expression profiling identifies genes associated with colorectal liver metastasis.

Lin HM, Chatterjee A, Lin YH, Anjomshoaa A, Fukuzawa R, McCall JL, Reeve AE.

Oncol Rep. 2007 Jun;17(6):1541-9.

PMID:
17487416
18.

Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.

Humar B, Fukuzawa R, Blair V, Dunbier A, More H, Charlton A, Yang HK, Kim WH, Reeve AE, Martin I, Guilford P.

Cancer Res. 2007 Mar 15;67(6):2480-9.

19.

Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.

Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507.

20.

Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.

Fukuzawa R, Heathcott RW, More HE, Reeve AE.

J Clin Pathol. 2007 Sep;60(9):1013-6. Epub 2006 Dec 15. Erratum in: J Clin Pathol. 2007 Nov;60(11):1296.

21.

Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.

Breslow NE, Beckwith JB, Perlman EJ, Reeve AE.

Pediatr Blood Cancer. 2006 Sep;47(3):260-7.

22.

Correct usage of "loss of imprinting".

Fukuzawa R, Reeve AE, Morison IM.

Am J Med Genet A. 2005 Nov 1;138(4):412; author reply 413-4. No abstract available.

PMID:
16222659
23.

A gene expression signature for relapse of primary wilms tumors.

Li W, Kessler P, Yeger H, Alami J, Reeve AE, Heathcott R, Skeen J, Williams BR.

Cancer Res. 2005 Apr 1;65(7):2592-601.

24.

Imprinting, expression, and localisation of DLK1 in Wilms tumours.

Fukuzawa R, Heathcott RW, Morison IM, Reeve AE.

J Clin Pathol. 2005 Feb;58(2):145-50.

25.

Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells.

Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okamoto K.

Oncogene. 2004 Aug 12;23(36):6163-9.

PMID:
15195139
26.

The MET proto-oncogene is not a major target for the gain of chromosome 7 in testicular germ-cell tumors of adolescents.

Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okada Y.

Virchows Arch. 2004 May;444(5):480-1. Epub 2004 Mar 6. No abstract available.

PMID:
15007647
27.

Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.

Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE.

Pediatr Dev Pathol. 2004 Mar-Apr;7(2):125-37. Epub 2004 Mar 4. Erratum in: Pediatr Dev Pathol. 2004 Sep-Oct;7(5):549.

PMID:
14994125
28.

Epigenetic differences between Wilms' tumours in white and east-Asian children.

Fukuzawa R, Breslow NE, Morison IM, Dwyer P, Kusafuka T, Kobayashi Y, Becroft DM, Beckwith JB, Perlman EJ, Reeve AE.

Lancet. 2004 Feb 7;363(9407):446-51.

PMID:
14962525
29.
30.

Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas.

Kawakami T, Okamoto K, Kataoka A, Koizumi S, Iwaki H, Sugihara H, Reeve AE, Ogawa O, Okada Y.

Genes Chromosomes Cancer. 2003 Sep;38(1):97-101.

PMID:
12874790
31.

The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.

Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okada Y.

J Urol. 2003 Apr;169(4):1546-52.

PMID:
12629412
32.

Re: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.

Morison IM, Becroft DM, Reeve AE.

J Natl Cancer Inst. 2002 Dec 4;94(23):1809; author reply 1809-10. No abstract available.

PMID:
12464656
33.

Chromosome 14q LOH in localized clear cell renal cell carcinoma.

Mitsumori K, Kittleson JM, Itoh N, Delahunt B, Heathcott RW, Stewart JH, McCredie MR, Reeve AE.

J Pathol. 2002 Sep;198(1):110-4.

PMID:
12210070
34.

Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression.

Kerr NJ, Chun YH, Yun K, Heathcott RW, Reeve AE, Sullivan MJ.

Med Pediatr Oncol. 2002 Jul;39(1):52-4. No abstract available.

PMID:
12116082
35.

Insulin-like growth factor-II imprinting in cancer.

Reeve AE, Becroft DM, Morison IM, Fukuzawa R.

Lancet. 2002 Jun 15;359(9323):2050-1. No abstract available.

PMID:
12086755
36.

Beckwith-Wiedemann syndrome, pancreatoblastoma, and the wnt signaling pathway.

Kerr NJ, Fukuzawa R, Reeve AE, Sullivan MJ.

Am J Pathol. 2002 Apr;160(4):1541-2; author reply 1542. No abstract available. Erratum in: Am J Pathol 2003 Jan;162(1):359. Fukazawa Ryuji [corrected to Fukuzawa Ryuji].

37.

A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.

Heathcott RW, Morison IM, Gubler MC, Corbett R, Reeve AE.

Hum Mutat. 2002 Apr;19(4):462. Review.

PMID:
11933209
39.

Preferential loss of maternal 9p alleles in childhood acute lymphoblastic leukemia.

Morison IM, Ellis LM, Teague LR, Reeve AE.

Blood. 2002 Jan 1;99(1):375-7.

40.

The future of high speed molecular biology in medicine.

Pattison ST, Reeve AE.

N Z Med J. 2001 Feb 23;114(1126):70-2. No abstract available.

PMID:
11280430
41.

Imprinting of insulin-like growth factor 2 is modulated during hematopoiesis.

Morison IM, Eccles MR, Reeve AE.

Blood. 2000 Nov 1;96(9):3023-8.

42.

Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann-beckwith syndrome.

Itoh N, Becroft DM, Reeve AE, Morison IM.

Am J Med Genet. 2000 May 15;92(2):111-6.

PMID:
10797434
43.

Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.

Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE.

Oncogene. 1999 Dec 9;18(52):7527-34.

44.

3' BCR recombines with IGL locus in BCR-ABL-positive philadelphia-negative chronic myeloid leukemia.

Benjes SM, Millow LJ, Jeffs AR, Sowerby SJ, Reeve AE, Morris CM.

Genes Chromosomes Cancer. 1999 Dec;26(4):366-71.

PMID:
10534772
45.

Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor.

Frevel MA, Sowerby SJ, Petersen GB, Reeve AE.

J Biol Chem. 1999 Oct 8;274(41):29331-40.

46.

E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.

Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MP, Reeve AE.

Hum Mutat. 1999;14(3):249-55.

PMID:
10477433
47.

Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR.

Yun K, Soejima H, Merrie AE, McCall JL, Reeve AE.

J Pathol. 1999 Apr;187(5):518-22.

PMID:
10398115
48.

Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations.

Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, Hunter A, Reeve AE, Sugimura H, Yamaguchi N, Yokota J.

Carcinogenesis. 1999 Jun;20(6):1127-31.

PMID:
10357799
49.

A potential imprint control element: identification of a conserved 42 bp sequence upstream of H19.

Frevel MA, Hornberg JJ, Reeve AE.

Trends Genet. 1999 Jun;15(6):216-8. No abstract available.

PMID:
10354581
50.

E-cadherin unlikely to be a common "low penetrance" gene for colorectal cancer.

Gardner RJ, Gaff CL, Macrae FA, St John DJ, Hopkins J, Guilford PJ, Reeve AE.

Am J Med Genet. 1999 May 21;84(2):169-71. No abstract available.

PMID:
10323744

Supplemental Content

Loading ...
Support Center